Article
ILT4 and its R20H variant as marker of poor prognosis in Spanish patients with colorectal cancer.
Human immunology - 1 Mar 2026
Fernández-Uría Sandra, Vaquero-Yuste Christian, Álvarez-González Elena, Del Pueblo Cristina Sánchez, Suárez-Solís María Luisa, Mugüerza-Huguet José María, Arnaiz-Villena Antonio, Martín-Villa José Manuel, Juarez Ignacio
Abstract excerpt
BACKGROUND: Immune checkpoint blockade is proving beneficial for cancer treatment by stimulating the anti-tumor immune response. However, the lack of success in certain cancer types encourages the research of new potential targets. ILT4 (Immunoglobulin-like transcript 4) is a transmembrane protein that binds with high affinity to HLA-G molecules present on tumor cells, modulating responses mediated by monocytes,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
